BALL vs. BMY
BALL (Ball Corporation) and BMY (Bristol-Myers Squibb Company) are both stocks. BALL operates in Packaging & Containers (Consumer Cyclical), while BMY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, BALL returned 5.84%/yr vs 1.00%/yr for BMY. At a 0.25 correlation, their price movements are largely independent.
Performance
BALL vs. BMY - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with BALL having a 8.29% return and BMY slightly lower at 8.27%. Over the past 10 years, BALL has outperformed BMY with an annualized return of 5.84%, while BMY has yielded a comparatively lower 1.00% annualized return.
BALL
- 1D
- 1.14%
- 1M
- 3.60%
- YTD
- 8.29%
- 6M
- 12.67%
- 1Y
- 6.33%
- 3Y*
- 3.03%
- 5Y*
- -5.69%
- 10Y*
- 5.84%
BMY
- 1D
- 0.40%
- 1M
- 0.23%
- YTD
- 8.27%
- 6M
- 11.43%
- 1Y
- 20.57%
- 3Y*
- 0.45%
- 5Y*
- 0.73%
- 10Y*
- 1.00%
BALL vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BALL Ball Corporation | 8.29% | -2.43% | -2.96% | 14.15% | -46.23% | 4.12% | 45.19% | 41.83% | 22.65% | 1.79% |
BMY Bristol-Myers Squibb Company | 8.27% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Correlation
The correlation between BALL and BMY is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.25 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Sep 7, 1984 | 0.25 |
Fundamentals
BALL:
$15.24B
BMY:
$116.75B
BALL:
$3.45
BMY:
$3.57
BALL:
16.52
BMY:
16.02
BALL:
0.17
BMY:
0.91
BALL:
1.13
BMY:
2.40
BALL:
2.12
BMY:
5.82
BALL:
$13.64B
BMY:
$48.48B
BALL:
$1.50B
BMY:
$33.33B
BALL:
$1.65B
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BALL vs. BMY — Risk / Return Rank
BALL
BMY
BALL vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ball Corporation (BALL) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BALL | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.50 | ||
| Sortino ratioReturn per unit of downside risk | -0.71 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.14 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 0.22 | 1.53 | -1.31 |
| Martin ratioReturn relative to average drawdown | 0.38 | 3.32 | -2.94 |
Loading charts...
Drawdowns
BALL vs. BMY - Drawdown Comparison
The maximum BALL drawdown since its inception was -55.09%, smaller than the maximum BMY drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for BALL and BMY.
Loading charts...
Drawdown Indicators
| BALL | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.09% | -72.03% | +16.94% |
Max Drawdown (1Y)Largest decline over 1 year | -21.96% | -12.05% | -9.91% |
Max Drawdown (3Y)Largest decline over 3 years | -35.62% | -36.85% | +1.23% |
Max Drawdown (5Y)Largest decline over 5 years | -55.09% | -47.67% | -7.42% |
Max Drawdown (10Y)Largest decline over 10 years | -55.09% | -47.67% | -7.42% |
Current DrawdownCurrent decline from peak | -37.91% | -17.79% | -20.12% |
Average DrawdownAverage peak-to-trough decline | -16.49% | -22.38% | +5.89% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.70% | 6.34% | +6.36% |
Volatility
BALL vs. BMY - Volatility Comparison
The current volatility for Ball Corporation (BALL) is 7.41%, while Bristol-Myers Squibb Company (BMY) has a volatility of 8.22%. This indicates that BALL experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BALL | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.41% | 8.22% | -0.81% |
Volatility (6M)Calculated over the trailing 6-month period | 19.80% | 18.18% | +1.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.16% | 27.08% | -0.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.42% | 24.02% | +6.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.33% | 25.29% | +3.04% |
Dividends
BALL vs. BMY - Dividend Comparison
BALL's dividend yield for the trailing twelve months is around 1.40%, less than BMY's 4.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BALL Ball Corporation | 1.40% | 1.51% | 1.45% | 1.39% | 1.56% | 0.73% | 0.64% | 0.85% | 0.87% | 0.96% | 0.69% | 0.71% |
BMY Bristol-Myers Squibb Company | 4.38% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
Financials
BALL vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Ball Corporation and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BALL vs. BMY - Profitability Comparison
BALL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ball Corporation reported a gross profit of 0.00 and revenue of 3.60B. Therefore, the gross margin over that period was 0.0%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
BALL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ball Corporation reported an operating income of 205.00M and revenue of 3.60B, resulting in an operating margin of 5.7%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
BALL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ball Corporation reported a net income of 205.00M and revenue of 3.60B, resulting in a net margin of 5.7%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
BALL and BMY have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BMY has higher volatility (8.22%) compared to BALL (7.41%). In terms of maximum drawdown, BALL dropped -55.09% vs BMY's -72.03%.
BMY currently has the higher Sharpe Ratio (0.68 vs 0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BALL and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer